Personalized medicine and public health: research syntheses mapping
Mapping review
|Published
This report seeks to explore the interface between personalized medicine and public health.
Key message
This mapping review within personalized medicine and public health has been done as an internal commission at the National Institute of Public Health. The report will be part of a strategic discussion on personalized medicine, public health and the National Institute of Public Health's future role in this field. The commission was partially due to assignments from The Ordering Forum to the Norwegian Institute of Public Health on Health Technology Assessment (HTA) concerning cancer treatment and diagnostic tests. Cancer is an important public health matter, but by no means the only one. This report seeks to explore the interface between personalized medicine and public health.
To obtain an overview of existing systematic reviews, we mapped systematic reviews pertaining to personalized medicine and public health. We performed our search in research databases and applied and evaluated studies according to pre-defined inclusion criteria.
We included four systematic reviews about personalized medicine and public health.
- The term of public health allows for inclusion of different types of illnesses, but the two disease-specific reviews that was included focused on prostatic and pancreatic cancer.
- Two systematic reviews assessed new technology and innovation by summarizing studies on genome-wide association studies (GWAS) and artificial intelligence
